The success of copyright’s blockbuster initially fueled a surge for pharma, however recent shifts present a murky picture for investors. Lower-cost competitors are eroding profits, and persistent patent challenges https://woodybroz529907.alltdesign.com/the-blue-pill-and-big-pharma-a-risky-bet-59904800